CV Sciences, Inc. (CVSI)
OTCMKTS · Delayed Price · Currency is USD
0.0340
+0.0040 (13.33%)
Dec 15, 2025, 4:00 PM EST
CV Sciences Market Cap
CV Sciences has a market cap or net worth of $6.15 million as of December 15, 2025. Its market cap has decreased by -16.29% in one year.
Market Cap
6.15M
Enterprise Value
7.14M
Revenue
14.37M
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.03
Market Cap Chart
Since November 9, 2011, CV Sciences's market cap has increased from 3.71M to 6.15M, an increase of 65.89%. That is a compound annual growth rate of 3.65%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 15, 2025 | 6.15M | -1.18% |
| Dec 31, 2024 | 6.23M | 13.96% |
| Dec 29, 2023 | 5.47M | 10.51% |
| Dec 30, 2022 | 4.95M | -62.06% |
| Dec 31, 2021 | 13.04M | -72.32% |
| Dec 31, 2020 | 47.10M | -50.85% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Veradigm | 841.30M |
| Glass House Brands | 743.26M |
| Elite Pharmaceuticals | 537.17M |
| CytoDyn | 407.36M |
| Northwest Biotherapeutics | 368.73M |
| American Oncology Network | 365.47M |
| Silence Therapeutics | 298.52M |
| Nika Pharmaceuticals | 291.10M |